本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Addex Therapeutics Ltd

7.54
+0.44006.20%
盤後7.53-0.0100-0.13%16:00 EDT
成交量:5,350.00
成交額:4.03萬
市值:805.95萬
市盈率:1.01
高:7.89
開:7.41
低:6.90
收:7.10
資料載入中...
2024/08/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/04/18

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/12/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/30

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/01

SEC問詢函

Form CORRESP - Correspondence
2023/06/01

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/05/12

SEC問詢函

Form CORRESP - Correspondence
2023/05/11

SEC問詢函

Form CORRESP - Correspondence
2023/05/11

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2023/05/03

招股説明書

F-1 - Registration statement for certain foreign private issuers
2023/04/10

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/04/05

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]